Compass Oncology

Tigard, Oregon 97223

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Transitional Cell, DCIS, Ductal Breast Carcinoma In Situ, Stage 0 Breast Cancer

Studies at this site

• The PREDICT Registry: — Recruiting now
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed